Steward Partners Investment Advisory’s Portola Pharmaceuticals, Inc. PTLA Stock Holding History

Steward Partners Investment Advisory’s Portfolio PTLA Stock Details PTLA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q3	–	Sell	-100	Closed	-$2K	–	2930
2020 Q2	$2K	Sell	100 -200	-67%	-$2.78K	﹤0.01%	2530
2020 Q1	$2K	Hold	300	–	–	﹤0.01%	2347
2019 Q4	$7K	Sell	300 -550	-65%	-$15.2K	﹤0.01%	2165
2019 Q3	$22K	Buy	850 +550	+183%	+$15.4K	﹤0.01%	1699
2019 Q2	$8K	Buy	+300	New	+$9.41K	﹤0.01%	2105
2018 Q4	–	Sell	-369	Closed	-$10K	–	2472
2018 Q3	$10K	Hold	369	–	–	﹤0.01%	1899
2018 Q2	$14K	Hold	369	–	–	﹤0.01%	1633
2018 Q1	$12K	Hold	369	–	–	﹤0.01%	1531
2017 Q4	$17K	Buy	369 +255	+224%	+$12.9K	﹤0.01%	1196
2017 Q3	$6K	Hold	114	–	–	﹤0.01%	1267
2017 Q2	$6K	Hold	114	–	–	﹤0.01%	1198
2017 Q1	$4K	Buy	+114	New	+$3.63K	﹤0.01%	1203

Steward Partners Investment Advisory's PTLA Position: Q3 2020 in Review

Steward Partners Investment Advisory sold out of Portola Pharmaceuticals, Inc. (PTLA) in Q3 2020, closing a stake of 100 shares — an estimated $2K sold.

Steward Partners Investment Advisory first reported a position in PTLA in Q1 2017 and held it in 12 quarters. The position peaked at $22K in Q3 2019. 0 funds tracked by Wall St. Rank hold PTLA as of Q3 2020.

Steward Partners Investment Advisory reported no remaining Portola Pharmaceuticals, Inc. position as of Q3 2020 after selling out during the quarter.
Steward Partners Investment Advisory sold 100 Portola Pharmaceuticals, Inc. shares in Q3 2020, an estimated $2K.
Steward Partners Investment Advisory first reported a position in Portola Pharmaceuticals, Inc. in Q1 2017 and held it in 12 quarters.
Steward Partners Investment Advisory's Portola Pharmaceuticals, Inc. position peaked at $22K in Q3 2019.
0 funds tracked by Wall St. Rank held Portola Pharmaceuticals, Inc. as of Q3 2020.

Based on Steward Partners Investment Advisory's 13F filing for Q3 2020, filed 30 Oct 2020.